These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20080116)

  • 1. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
    Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteins.
    Luna-Tortós C; Rambeck B; Jürgens UH; Löscher W
    Pharm Res; 2009 Nov; 26(11):2464-70. PubMed ID: 19730994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
    Römermann K; Helmer R; Löscher W
    Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
    Pratt S; Chen V; Perry WI; Starling JJ; Dantzig AH
    Eur J Pharm Sci; 2006 Apr; 27(5):524-32. PubMed ID: 16337112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
    Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
    de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
    Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role for human P-glycoprotein in the transport of lacosamide.
    Zhang C; Chanteux H; Zuo Z; Kwan P; Baum L
    Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2).
    Williams GC; Liu A; Knipp G; Sinko PJ
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3456-62. PubMed ID: 12384350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.
    Prime-Chapman HM; Fearn RA; Cooper AE; Moore V; Hirst BH
    J Pharmacol Exp Ther; 2004 Nov; 311(2):476-84. PubMed ID: 15210835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
    Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
    Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.
    van Vliet EA; Redeker S; Aronica E; Edelbroek PM; Gorter JA
    Epilepsia; 2005 Oct; 46(10):1569-80. PubMed ID: 16190927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
    Potschka H; Fedrowitz M; Löscher W
    Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
    Potschka H; Fedrowitz M; Löscher W
    J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
    Zhang C; Kwan P; Zuo Z; Baum L
    Life Sci; 2010 Jun; 86(23-24):899-905. PubMed ID: 20417647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
    Zhang C; Zuo Z; Kwan P; Baum L
    Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines.
    Dogan AL; Legrand O; Faussat AM; Perrot JY; Marie JP
    Leuk Res; 2004 Jun; 28(6):619-22. PubMed ID: 15120939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.
    Agarwal S; Pal D; Mitra AK
    Int J Pharm; 2007 Jul; 339(1-2):139-47. PubMed ID: 17451894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.